| Net income | 4.31M |
| Depreciation and amortization | 4.4M |
| Provision for doubtful accounts | 7.53M |
| Deferred income taxes | 803K |
| Excess tax benefit from stock option exercises | |
| Stock-based compensation expense | 721K |
| Other | |
| Restricted cash | 130K |
| Accounts receivable | -9.69M |
| Accounts payable | 1.41M |
| Other operating assets and liabilities | -2.03M |
| Deferred revenue | -20.17M |
| Net cash flows from operating activities | |
| Facility expenditures and land purchases | |
| Capital expenditures, net | |
| Proceeds from sales and maturities of investments and repayment of notes | |
| Purchase of investments and note advances | |
| Net cash flows from investing activities | |
| Excess tax benefit from stock option exercises | |
| Proceeds from exercise of stock options | |
| Repurchase of common stock and shares tendered for taxes | |
| Net cash flows from financing activities | |
| Net change in cash and cash equivalents | -30.66M |
| Cash and cash equivalents at beginning of period | 108.66M |
| Cash and cash equivalents at end of period | 78M |